| Articles | October 1, 2011
Contemporary Pediatrics, Digital Edition, October 2011
Screening adolescents for Bariatric Surgery : When diet, exercise just aren't enough
Bats! 3 steps for rabies exposure prophylaxis
Dermcase : Atrophic scars and poor wound healing in young boy
Puzzler : Abrupt, intermittent pain and fever, but no apparent cause
Updates : Infant formula, CDC on Flu vaccination, Medication poisoning, Antibiotics, AAP on Poliovirus, Varicella, Hepatitis A and Tdap
Newsletter Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Subscribe
November 17th, 2026 The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
November 17th, 2026 The US lost measles elimination status after 26 years; CDC and partners plan to regain it via MMR vaccination and $100M in health department funding.
November 17th, 2026 At ACAAI 2026, 93.6% of pediatric biologic prescriptions needed prior authorization, 39.3% were denied, and approval took a mean of 33 days.
November 17th, 2026 US preterm birth rate held at 10.4%, earning a fifth straight D+ from March of Dimes; maternal deaths fell, but racial disparities persist.
November 16th, 2026 In SURMOUNT-ADOLESCENTS, tirzepatide cut BMI 18.5% at 72 weeks vs a 0.5% rise with placebo in adolescents with obesity.
November 16th, 2026 Data presented at NSGC 2026 tie maternal autoantibody combinations to a non-genetic autism subtype with high recurrence risk in later-born siblings.
November 16th, 2026 Caregivers reported itch, symptom, and QOL gains with roflumilast cream 0.05% in infants with AD; an FDA decision is due February 2027.
November 16th, 2026 Novo Nordisk filed etavopivat for SCD in patients aged 12+, backed by phase 3 HIBISCUS data showing a 27% drop in vaso-occlusive crises vs placebo.